Evidence map›Paper›PMID 41897478›Full record

ReviewAntioxidants (Basel, Switzerland)2026

Dermocosmetic Potential of

Nerea Pons-Rocamora, Enrique Barrajón-Catalán, María Herranz-López, Vicente Micol, Francisco Javier Álvarez-Martínez

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nerea Pons-RocamoraInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández (UMH), 03202 Elche, Spain.ORCID 0009-0000-9785-5002
Enrique Barrajón-CatalánInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández (UMH), 03202 Elche, Spain.ORCID 0000-0001-8113-0795
María Herranz-LópezInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández (UMH), 03202 Elche, Spain.ORCID 0000-0002-1819-7978
Vicente MicolInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández (UMH), 03202 Elche, Spain.ORCID 0000-0001-8089-0696
Francisco Javier Álvarez-MartínezInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández (UMH), 03202 Elche, Spain.ORCID 0000-0002-5275-1282

Funding

Daniel and Nina Carasso Foundation Daniel Carasso FellowshipGeneralitat Valenciana CIAPOT/2023/017Generalitat Valenciana INNEST/2022/103Generalitat Valenciana PROMETEO/2021/059Instituto de Salud Carlos III CB12/03/30038Spanish Ministry of Economy and Competitiveness PID2021-125188OB-C32Spanish Ministry of Economy and Competitiveness RTI2018-096724-B-C22Spanish Ministry of Economy and Competitiveness TED2021-129932B-C21Spanish Ministry of Universities Requalification for university teachers grant
6 · The paper itself

Abstract

backgroundPURPOSE: This systematic review aimed to evaluate the skin-related biological activities of pomegranate extracts, identify the key bioactive compounds involved, and elucidate the underlying molecular mechanisms relevant to skin health and aging.

methodsA total of 732 studies were screened using AIReviewer clustering. Fifty-four original articles were selected on the basis of inclusion criteria prioritizing molecular evidence,

resultsPomegranate extracts exhibit a broad range of dermocosmetic properties, including antioxidant, anti-inflammatory, antibacterial, wound healing, moisturizing, photoprotective, and collagen-preserving effects. These effects are primarily attributed to ellagitannins (punicalagin and punicalin), ellagic and gallic acid, triterpenoids (oleanolic, maslinic, and asiatic acids), flavonoids (quercetin and catechins), anthocyanins, and fatty acids (punicic acid). Pomegranate extracts modulate oxidative stress by scavenging reactive oxygen species and upregulating Nrf2-mediated antioxidant pathways. They inhibit matrix metalloproteinases (MMP-1 and MMP-3), suppress proinflammatory cytokines (TNF-α and IL-6), and stimulate fibroblast proliferation, extracellular matrix remodeling, and hyaluronic acid synthesis. Their photoprotective activity provides enhanced UVB resistance and higher SPF values. Recent advances in fermentation and nanotechnology have been shown to increase the bioavailability and stability of compounds found in pomegranate, offering new formulation strategies.

conclusionsPomegranates are a promising source of multifunctional phytochemicals with validated dermocosmetic applications. Their incorporation into advanced delivery systems may increase their therapeutic potential for skin protection, regeneration, and antiaging interventions.

Indexed as

agingantioxidantdermocosmeticextractpolyphenolpomegranateskin

Identifiers

PMID41897478
PMCPMC13024184

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.